Pegylated Liposomal Doxorubicin: Tolerability and Toxicity
- 作者Dr. Adrian L. Goram; Ms. Perry L. Richmond
- 卷第21卷
- 期第6期
- 印刷ISSN1875-9114
- 文件大小67.77KB
- 发表时间2001
- DOI10.1592/phco.21.7.751.34572
- 页码751-763
The Essential Research Curriculum for Doctor of Pharmacy Degree ProgramsMary W. Lee; Patrick G. Clay; W. Klugh Kennedy; Mary Jayne Kennedy; Nicole M. Sifontis; Dana Simonson; Kevin M. Sowinski; William J. Taylor; Robyn M. Teply; Orly Vardeny; Timothy E. Welty; American College of Clinical Pharmacy · 2010
Personalized medicines – are pharmacists ready for the challenge?Kennedy, Mary Jayne · Integrated Pharmacy Research and Practice · 2018
Current Status of Gene Therapy for Cystic Fibrosis Pulmonary DiseaseKennedy, Mary Jayne · American Journal of Respiratory Medicine · 2002
Receptor-Mediated Endocytosis across Human Placenta: Emphasis on MegalinAkour, Amal A.; Kennedy, Mary Jayne; Gerk, Phillip · Molecular Pharmaceutics · 2013
Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and AdolescentsMary Jayne Kennedy, Kevin D. Jellerson, Michael Z. Snow… · 2013
Comparison of Various Urine Collection Intervals for Caffeine and Dextromethorphan Phenotyping in ChildrenKennedy, Mary Jayne; Abdel-Rahman, Susan M.; Kashuba, Angela D. M.; Leeder, J. Steven · The Journal of Clinical Pharmacology · 2004
The Role of the Pediatric Pharmacist in Precision Medicine and Clinical Pharmacogenomics for ChildrenBrown, Jacob T.; Gregornik, David; Kennedy, Mary Jayne · The Journal of Pediatric Pharmacology and Therapeutics · 2018